Bayer to sell animal health unit to ElancoAugust 20, 2019
By The Associated Press
FRANKFURT, Germany — Indiana-based Elanco Animal Health says it has agreed to buy the veterinary medicines business of Germany's Bayer AG for $7.6 billion in cash and stock.
Elanco said in a news release Tuesday that the deal would mean an expanded portfolio of treatments as well as more efficiencies and increased profit margins.
The sale is part of Bayer's plan to divest several of its businesses including its Dr. Scholl's foot care products brand and Coppertone sunscreen.
The deal consists of $5.3 billion in cash and $2.3 billion in Elanco stock. It is expected to close in mid-2020 subject to approval by antitrust authorities.
Elanco, headquartered in Greenfield, Indiana, makes medicines for both farm animals and pets. It has 5,800 employees and is active in more than 90 countries.
More on DuboisCountyHerald.com
The Dubois County Health Department confirms seven more positive cases of novel coronavirus,...
Celestine Elementary’s Last Year
The Dubois County Health Department confirms two more positive cases of novel coronavirus,...
Of the 169 Dubois County residents who have tested positive for COVID-19, a total of six have...
Three candidates are seeking the Democratic nomination for District 8 U.S. Representative.
Southridge High School graduated 116 in the Class of 2020 last week when e-learning came to an...
Gov. Eric J. Holcomb announced that because health indicators remain positive, most of the state...
The Dubois County Health Department confirms six more positive cases of novel coronavirus,...